• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养保健品在治疗勃起功能障碍中的作用:磷酸二酯酶-5 酶抑制作用:小型综述。

Role of Nutraceuticals in Treating Erectile Dysfunction Inhibition of Phosphodiesterase-5 Enzyme: A Mini Review.

机构信息

School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India.

Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, 11942, Saudi Arabia.

出版信息

Curr Pharm Biotechnol. 2024;25(15):1905-1914. doi: 10.2174/0113892010256035231119071714.

DOI:10.2174/0113892010256035231119071714
PMID:38310448
Abstract

Erectile Dysfunction (ED) is a prevalent sexual health condition affecting a significant portion of the male population worldwide. The conventional therapeutic approaches for ED often involve the use of pharmaceutical agents targeting the phosphodiesterase-5 (PDE5) enzyme. Currently, treatment with PDE-5 inhibitors is the standard approach for ED, and four PDE-5 inhibitors, namely sildenafil, vardenafil, tadalafil, and avanafil, are in use. However, these pharmaceutical interventions may be associated with adverse effects and limitations. As a result, there has been a growing interest in exploring alternative and complementary treatment options for ED, such as nutraceuticals, which are bioactive compounds derived from natural sources. Nutraceuticals, which include vitamins, minerals, herbs, and other dietary supplements, have gained popularity for their potential health benefits. Certain nutraceuticals have demonstrated the ability to modulate various physiological pathways, including those involved in erectile function. A notable mechanism of action is the inhibition of the PDE5 enzyme, which plays a pivotal role in the regulation of cGMP levels. By inhibiting PDE5, nutraceuticals can promote the accumulation of cGMP, leading to enhanced penile blood flow and improved erectile function. A comprehensive analysis of the literature showcases various nutraceutical agents, including plant-derived compounds like flavonoids, polyphenols, and amino acids which have exhibited PDE5 inhibitory effects. Mechanistic insights into their action involve modulation of NO release, cGMP elevation, and relaxation of penile smooth muscles, all critical factors for achieving and sustaining erections. This review focuses on elucidating the role of nutraceuticals in treating erectile dysfunction through the inhibition of the PDE5 enzyme.

摘要

勃起功能障碍(ED)是一种普遍存在的男性健康问题,影响着全球很大一部分男性人口。ED 的传统治疗方法通常涉及使用针对磷酸二酯酶-5(PDE5)酶的药物。目前,PDE-5 抑制剂的治疗是 ED 的标准方法,有四种 PDE-5 抑制剂,即西地那非、伐地那非、他达拉非和阿伐那非,正在使用。然而,这些药物干预可能会产生不良反应和限制。因此,人们越来越关注探索 ED 的替代和补充治疗方法,例如天然来源的生物活性化合物——营养保健品。营养保健品包括维生素、矿物质、草药和其他膳食补充剂,因其潜在的健康益处而受到欢迎。某些营养保健品已被证明能够调节多种生理途径,包括与勃起功能相关的途径。一个显著的作用机制是抑制 PDE5 酶,该酶在调节 cGMP 水平方面起着关键作用。通过抑制 PDE5,营养保健品可以促进 cGMP 的积累,从而增加阴茎血流量并改善勃起功能。对文献的综合分析展示了各种营养保健品,包括植物源性化合物,如类黄酮、多酚和氨基酸,它们具有抑制 PDE5 的作用。其作用的机制包括调节 NO 释放、cGMP 升高和阴茎平滑肌松弛,这些都是实现和维持勃起的关键因素。本综述重点探讨了通过抑制 PDE5 酶来治疗勃起功能障碍的营养保健品的作用。

相似文献

1
Role of Nutraceuticals in Treating Erectile Dysfunction Inhibition of Phosphodiesterase-5 Enzyme: A Mini Review.营养保健品在治疗勃起功能障碍中的作用:磷酸二酯酶-5 酶抑制作用:小型综述。
Curr Pharm Biotechnol. 2024;25(15):1905-1914. doi: 10.2174/0113892010256035231119071714.
2
Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.5型磷酸二酯酶作为勃起功能障碍的药物靶点
Urology. 2002 Sep;60(2 Suppl 2):4-11. doi: 10.1016/s0090-4295(02)01686-2.
3
Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway.奈必洛尔通过增强一氧化氮/环磷酸鸟苷(NO/cGMP)途径,增强磷酸二酯酶5(PDE5)抑制剂舒张糖尿病患者阴茎海绵体和阴茎动脉的功效。
J Sex Med. 2014 May;11(5):1182-92. doi: 10.1111/jsm.12477.
4
Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability.阿伐那非(一种用于治疗勃起功能障碍的 PDE5 抑制剂)的选择性:对临床安全性和改善耐受性的影响。
J Sex Med. 2012 Aug;9(8):2122-9. doi: 10.1111/j.1743-6109.2012.02822.x. Epub 2012 Jul 3.
5
Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.磷酸二酯酶 5 抑制剂治疗良性前列腺增生症下尿路症状的最新证据。
Eur Urol. 2016 Jul;70(1):124-133. doi: 10.1016/j.eururo.2015.12.048. Epub 2016 Jan 22.
6
Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy.5型磷酸二酯酶(PDE5)抑制剂治疗双侧保留神经根治性前列腺切除术后勃起功能障碍的疗效和安全性。
Andrologia. 2016 Feb;48(1):20-8. doi: 10.1111/and.12405. Epub 2015 Feb 15.
7
Natural phosphodiesterase 5 (PDE5) inhibitors: a computational approach.天然磷酸二酯酶 5(PDE5)抑制剂:一种计算方法。
Nat Prod Res. 2021 May;35(10):1648-1653. doi: 10.1080/14786419.2019.1619726. Epub 2019 May 29.
8
Avanafil for erectile dysfunction.阿伐那非治疗勃起功能障碍。
Ann Pharmacother. 2013 Oct;47(10):1312-20. doi: 10.1177/1060028013501989. Epub 2013 Sep 27.
9
Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.钙离子激活钾通道(KCa)刺激可提高磷酸二酯酶5抑制剂对人阴茎动脉的舒张能力,并恢复磷酸二酯酶5抑制在糖尿病性勃起功能障碍中降低的疗效。
Br J Pharmacol. 2013 May;169(2):449-61. doi: 10.1111/bph.12143.
10
Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction.阿伐那非,一种新型快速起效的磷酸二酯酶 5 抑制剂,用于治疗勃起功能障碍。
Expert Opin Investig Drugs. 2010 Nov;19(11):1427-37. doi: 10.1517/13543784.2010.518955. Epub 2010 Oct 13.

本文引用的文献

1
The role of microRNAs in erectile dysfunction: From pathogenesis to therapeutic potential.微小 RNA 在勃起功能障碍中的作用:从发病机制到治疗潜能。
Front Endocrinol (Lausanne). 2022 Oct 25;13:1034043. doi: 10.3389/fendo.2022.1034043. eCollection 2022.
2
Erectile dysfunction after COVID-19 recovery: A follow-up study.新冠病毒康复后出现勃起功能障碍:一项随访研究。
PLoS One. 2022 Oct 20;17(10):e0276429. doi: 10.1371/journal.pone.0276429. eCollection 2022.
3
Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis.
人脐带间充质干细胞通过减轻铁死亡改善糖尿病大鼠的勃起功能障碍。
Stem Cell Res Ther. 2022 Sep 5;13(1):450. doi: 10.1186/s13287-022-03147-w.
4
Novel predictive risk factor for erectile dysfunction: Serum high-sensitivity C-reactive protein.血清高敏 C 反应蛋白:勃起功能障碍的新预测风险因子。
Andrology. 2022 Sep;10(6):1096-1106. doi: 10.1111/andr.13206. Epub 2022 Jun 28.
5
Erectile Dysfunction in Multiple Sclerosis: A Prevalence Meta-Analysis and Systematic Review.多发性硬化症中的勃起功能障碍:患病率的荟萃分析和系统评价。
J Sex Med. 2022 Aug;19(8):1255-1268. doi: 10.1016/j.jsxm.2022.05.002. Epub 2022 Jun 11.
6
Mechanistic analysis of erectile dysfunction in a depression rat model.抑郁模型大鼠勃起功能障碍的机制分析。
J Int Med Res. 2022 May;50(5):3000605221100334. doi: 10.1177/03000605221100334.
7
An update on the current status and future prospects of erectile dysfunction following radical prostatectomy.根治性前列腺切除术后勃起功能障碍的现状和未来展望的最新进展。
Prostate. 2022 Sep;82(12):1135-1161. doi: 10.1002/pros.24366. Epub 2022 May 17.
8
Erectile dysfunction and premature ejaculation: a continuum movens supporting couple sexual dysfunction.勃起功能障碍和早泄:支持夫妻性障碍的连续运动。
J Endocrinol Invest. 2022 Nov;45(11):2029-2041. doi: 10.1007/s40618-022-01793-8. Epub 2022 May 3.
9
Dietary Supplements as Source of Unintentional Doping.膳食补充剂作为非故意兴奋剂的来源。
Biomed Res Int. 2022 Apr 22;2022:8387271. doi: 10.1155/2022/8387271. eCollection 2022.
10
Pharmacotherapy for Erectile Dysfunction in 2021 and Beyond.2021 年及以后的勃起功能障碍的药物治疗。
Urol Clin North Am. 2022 May;49(2):209-217. doi: 10.1016/j.ucl.2021.12.002.